Absolutely wild, isn't it? I wonder if someone (USYD/Cynata) will consider a partial data release like has been proposed with the diabetic foot ulcer trial? We know 190 patients were recruited as of November 2022, so these will all complete their 24 month reviews in November this year. Come on Killian/Hunter/Brooke - might be worth putting the misinformation to bed with some Australian clinical data!
Stem Cell News, page-488
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 28.0¢ | $1.401K | 5.004K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 10182 | 1 |
View Market Depth
| Last trade - 15.59pm 17/05/2024 (20 minute delay) ? |
| CYP (ASX) Chart |